Preexisting Antibodies to an F(ab′)2 Antibody Therapeutic and Novel Method for Immunogenicity Assessment
Anti-therapeutic antibodies (ATAs) may impact drug exposure and activity and induce immune complex mediated toxicity; therefore the accurate measurement of ATA is important for the analysis of drug safety and efficacy. Preexisting ATAs to the hinge region of anti-Delta like ligand 4 (anti-DLL4) F(ab...
Main Authors: | Jane Ruppel, Ann Brady, Rebecca Elliott, Cecilia Leddy, Marco Palencia, Daniel Coleman, Jessica A. Couch, Eric Wakshull |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/2921758 |
Similar Items
-
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
by: Jasmine Davda, et al.
Published: (2019-04-01) -
Antibody therapeutic prediction and design : immunogenicity and stability
by: Northey, T. C.
Published: (2017) -
Prediction of immunogenicity for humanized and full human therapeutic antibodies.
by: Shide Liang, et al.
Published: (2020-01-01) -
Immunogenicity of Bioproducts: Cellular Models to Evaluate the Impact of Therapeutic Antibody Aggregates
by: Myriam Nabhan, et al.
Published: (2020-05-01) -
The Therapeutic Value of Monoclonal Antibodies Directed Against Immunogenic Tumor Glycoproteins
by: Myron Arlen, Philip Arlen, Al Tsang, XuePing Wang, Rishab Gupta
Published: (2010-01-01)